Article info

Original research
Eculizumab versus rituximab in generalised myasthenia gravis

Authors

  1. Correspondence to Dr Tobias Ruck, Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany; Tobias.Ruck{at}med.uni-duesseldorf.de
View Full Text

Citation

Nelke C, Schroeter CB, Stascheit F, et al
Eculizumab versus rituximab in generalised myasthenia gravis

Publication history

  • Received December 16, 2021
  • Accepted February 22, 2022
  • First published March 4, 2022.
Online issue publication 
April 12, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.